Ritesh International announces 50% capacity expansion worth Rs 7 crore

Capex & Operations View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.8%Reaction day

₹73.50

prior close

₹77.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+4.6% vs market

Commodity Chemicals peers, median of 54sector-0.8%+5.6% vs sector

On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 5.6 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.8+0.1+4.6-0.8+5.6

Next day

+7.5+0.5+7.0-1.1+8.6

+7.4-0.1+7.5-3.1+10.5

+5.6+0.4+5.2-1.0+6.6

+5.4+0.7+4.8-2.0+7.4

+2.9+0.9+1.9-1.3+4.1

+5.0+1.1+3.9-0.9+5.9

15d

+8.8+1.6+7.2+0.5+8.4

+22.5-0.7+23.2-2.0+24.5

+22.7-3.2+25.9-2.5+25.2

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ritesh International is expanding manufacturing capacity by 50 percent, from 80 metric tons per day to 120 metric tons per day at its Ahmedgarh facility. Total capex is Rs 7 crore, funded by Rs 1 crore bank loan and Rs 6 crore from internal accruals. The company makes Stearic Acid, Fatty Acid and Glycerin. Expansion will complete in about 8 months, with commercial production targeted for Q1 FY27-28. The move aims to meet rising demand and strengthen market share.

Likely market impact

Signals revenue growth potential, funded mostly by internal accruals which limits debt risk. Execution timeline targets Q1 FY27-28.